IP Library Granted Patent US 8,435,190
Granted Patent B2
US 8,435,190 · App. 11/624,736 · Granted May 7, 2013

Method and apparatus for penetrating tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,435,190
App. No.
11/624,736
Granted
May 7, 2013
Kind
B2
Abstract

A tissue penetrating system includes a plurality of cartridges each with a distal port and a proximal port. A plurality of penetrating members are provided, each coupled to a cartridge and having a sharpened distal tip and a shaft portion slidably disposed within the cartridge. A seal is formed by a fracturable material between the penetrating member and the cartridge. The seal is positioned at one or both of a distal port or a proximal port of the cartridge.

Claims (36)

1. A tissue penetrating system, comprising:

a penetrating member driver;

a plurality of disposables each with a distal port and a proximal port;

a plurality of penetrating members each coupled to a disposable and a penetrating member driver, each penetrating member having a sharpened distal tip and a shaft portion slidably disposed within the disposable;

a plurality of analyte sensors each being associated with a penetrating member;

a seal formed by a fracturable material between the penetrating member and the disposable, the seal being positioned at least one of a distal port or a proximal port of the disposable;

a penetrating member position sensor coupled to the penetrating member driver, the position sensor utilizing position information of the each of a penetrating member to determine a depth of penetration through a skin surface;

a processor that reads and stores position data generated by the position sensor and measures an amount of skin elastic tenting; and

wherein the penetrating member driver is coupled to a processor and configured to provide that in a first direction the penetrating member moves toward the target tissue at a speed that is greater than a speed at which the penetrating member moves away from the target tissue.

2. The system of claim 1 , wherein a speed of a penetrating member in the first direction is the range of 0.05 to 60 m/sec.

3. The system of claim 1 , wherein a speed of a penetrating member in the first direction is the range of 0.1 to 20.0 m/sec.

4. The system of claim 1 , wherein a speed of a penetrating member in the first direction is the range of 1.0 to 10.0 m/sec.

5. The system of claim 1 , wherein a speed of a penetrating member in the first direction is the range of 3.0 to 8.0 m/sec.

6. The system of claim 1 , wherein a dwell time of the penetrating member in the target tissue below a skin surface is in the range of 1 microsecond to 2 seconds.

7. The system of claim 1 , wherein a dwell time of the penetrating member in the target tissue below a skin surface is in the range of 500 milliseconds to 1.5 second.

8. The system of claim 1 , wherein a dwell time of the penetrating member in the target tissue below a skin surface is in the range of 100 milliseconds to 1 second.

9. The system of claim 1 , further comprising:

a sample chamber with an opening for transport of a body fluid into the sample chamber, the sample chamber being sized to receive no more than 1.0 μL of the body fluid.

10. The system of claim 1 , further comprising:

a sample chamber with an opening for transport of a body fluid into the sample chamber, the sample chamber being sized to receive no more than 0.75 μL of the body fluid.

11. The system of claim 1 , further comprising:

a sample chamber with an opening for transport of a body fluid into the sample chamber, the sample chamber being sized to receive no more than 0.5 μL of the body fluid.

12. The system of claim 1 , further comprising:

a sample chamber with an opening for transport of a body fluid into the sample chamber, the sample chamber being sized to receive no more than 0.25 μL of the body fluid.

13. The system of claim 1 , further comprising:

a sample chamber with an opening for transport of a body fluid into the sample chamber, the sample chamber being sized to receive no more than 0.1 μL of the body fluid.

14. The system of claim 1 , further comprising:

a tissue stabilizer device coupled to the housing.

15. The system of claim 14 , wherein the tissue stabilizer device is configured to enhance fluid flow from a target tissue.

16. The system of claim 14 , wherein the tissue stabilizer device creates a stretching of a skin surface.

17. The system of claim 14 , wherein the tissue stabilizer device includes a plurality of protrusions.

18. The system of claim 14 , wherein the tissue stabilizer device applies a vacuum to a target tissue.

19. The system of claim 14 , wherein the tissue stabilizer device is configured to apply a force to a target tissue and cause the target tissue to press in an inward direction relative to the housing member.

20. The system of claim 14 , wherein the tissue stabilizing member applies a stimulation to a target tissue.

21. The system of claim 1 , further comprising

a second fracturable seal located at least one of the distal port or proximal port of disposable.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2012
From: PELIKAN TECHNOLOGIES, INC.
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 028397/0099 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 024016/0492 →
SECURITY AGREEMENT Recorded Dec 18, 2008
From: PELIKAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021998/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2007
From: FREEMAN, DOMINIQUE M; BOECKER, DIRK; ALDEN, DON
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 019086/0224 →